4 found
Order:
  1. The Leaning Tower of PISA: Fundamental Problems in Ignorance-Based Theories of State Autonomy.Daniel Carpenter - forthcoming - Critical Review: A Journal of Politics and Society.
  2.  35
    A Systematic Review of State and Manufacturer Physician Payment Disclosure Websites: Implications for Implementation of the Sunshine Act.Alison R. Hwong, Noor Qaragholi, Daniel Carpenter, Steven Joffe, Eric G. Campbell & Lisa Soleymani Lehmann - 2014 - Journal of Law, Medicine and Ethics 42 (2):208-219.
    Public disclosure of industry payments to physicians is one way to address financial conflicts of interest in medicine. As part of the Patient Protection and Affordable Care Act, the Physician Payment Sunshine Act requires pharmaceutical, medical device, and biologics manufacturers who have at least one product reimbursed by Medicare or Medicaid to disclose payments to physicians and teaching hospitals on a public website starting in 2014. The physician payment data will contain individual physician names, monetary values, and specific products connected (...)
    Direct download (2 more)  
     
    Export citation  
     
    Bookmark  
  3.  20
    The Leaning Tower of “Pisa”: Public Ignorance, Issue Publics, and State Autonomy: Reply to DeCanio.Daniel Carpenter - 2007 - Critical Review: A Journal of Politics and Society 19 (1):157-164.
    ABSTRACT In the pages of this journal, Samuel DeCanio and colleagues have advanced the proposition that public ignorance (PI) can lead to state autonomy (SA), inasmuch as the public cannot constrain state actions of which it is unaware. The pisa framework, while original and deserving of further research, needs to take account of complicating factors on both the public ignorance and the state autonomy sides of the equation. ?Knowledge,? and thus ?ignorance,? is a matter of diverse interpretations, so what seems (...)
    Direct download (3 more)  
     
    Export citation  
     
    Bookmark   1 citation  
  4.  2
    FDA Transparency in an Inescapably Political World.Daniel Carpenter - 2017 - Journal of Law, Medicine and Ethics 45 (s2):29-32.
    Transparency requires more than disclosure of data. It requires a mechanism and policy for conveying information to the public. In order for the aims of the excellent report of the FDA Transparency Working Group to be realized, a publicity initiative will need to accompany the plan of action. The FDA will need to actively convey information about the evidence concerning benefit-risk profiles of drugs, sometimes pointing out misleading claims by manufacturers or sponsors. In other cases, the FDA will need to (...)
    No categories
    Direct download (2 more)  
     
    Export citation  
     
    Bookmark